LINC02115

Across TCGA pan-cancer cohorts, LINC02115 RNA differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of LINC02115’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where LINC02115 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02115 is over-expressed in tumor, although a few such as STAD show the opposite, repressed pattern.

THCA, KICH, and LIHC are the cancer types where LINC02115 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02115 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Female	II,III,IV	+0.404	<.001	9	view →
KICH	All	All	+1.468	<.001	5	view →
LIHC	Female	II,III,IV	+0.089	.023	4	view →
CHOL	All	All	+0.374	.004	2	view →
BLCA	Female	III,IV	+0.235	.010	2	view →
STAD	All	II,III,IV	−0.138	.029	1	view →
KIRC	All	All	+0.067	.041	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

LINC02115–THCA

Open the THCA breakdown →